FDA Watch: OraSure’s Collection Device for Cobas STI Testing Receives Approval
At-home sample collections can be mailed to a clinical laboratory
At-home sample collections can be mailed to a clinical laboratory
From – National Intelligence Report
The U.S. Food and Drug Administration (FDA) released another draft guidance document last week that addresses…
From – National Intelligence Report
Promoting flexibility and efficiency, the U.S. Food and Drug Administration (FDA) issued two draft guidances last week addressing oversight of…
From – National Intelligence Report
Roche announced last week that the U.S. Food and Drug Administration (FDA) approved the cobas® EGFR Mutation Test v2 “for use with…